ID: ALA5283749

Max Phase: Preclinical

Molecular Formula: C66H114N6O18

Molecular Weight: 1279.66

Associated Items:

Representations

Canonical SMILES:  CCCCC[C@@H]1OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C1=O

Standard InChI:  InChI=1S/C66H114N6O18/c1-19-25-31-37-49-55(73)67(13)44(8)62(80)86-51(39-33-27-21-3)57(75)69(15)46(10)64(82)88-53(41-35-29-23-5)59(77)71(17)48(12)66(84)90-54(42-36-30-24-6)60(78)72(18)47(11)65(83)89-52(40-34-28-22-4)58(76)70(16)45(9)63(81)87-50(38-32-26-20-2)56(74)68(14)43(7)61(79)85-49/h43-54H,19-42H2,1-18H3/t43-,44-,45-,46-,47-,48-,49+,50+,51+,52+,53+,54+/m1/s1

Standard InChI Key:  OGVFBXYJBMIQID-ICAFVNMOSA-N

Associated Targets(non-human)

Ryanodine receptor 2 21 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1279.66Molecular Weight (Monoisotopic): 1278.8190AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Smith AN, Blackwell DJ, Knollmann BC, Johnston JN..  (2021)  Ring Size as an Independent Variable in Cyclooligomeric Depsipeptide Antiarrhythmic Activity.,  12  (12.0): [PMID:34917258] [10.1021/acsmedchemlett.1c00508]

Source